Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study
- Resource Type
- Source
- Clinical Lung Cancer. 24:218-227
- Subject
Pulmonary and Respiratory Medicine Cancer Research Oncology - Language
- ISSN
- 1525-7304